G01N 2800/323
Arteriosclerosis, stenosis
Official title: Arteriosclerosis, Stenosis
G01N2800/323 (Arteriosclerosis, stenosis) appears on 281 US grants and 428 published applications in this corpus.
Search patents in G01N- Granted patents
- 281
- Published applications
- 428
- Assignees
- 283
- Inventors
- 741
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 16 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 4 |
| 2002 | 6 | 11 |
| 2003 | 9 | 23 |
| 2004 | 6 | 17 |
| 2005 | 4 | 15 |
| 2006 | 6 | 14 |
| 2007 | 10 | 28 |
| 2008 | 9 | 20 |
| 2009 | 11 | 28 |
| 2010 | 18 | 31 |
| 2011 | 17 | 29 |
| 2012 | 11 | 23 |
| 2013 | 22 | 28 |
| 2014 | 15 | 18 |
| 2015 | 18 | 17 |
| 2016 | 11 | 19 |
| 2017 | 9 | 13 |
| 2018 | 7 | 13 |
| 2019 | 9 | 15 |
| 2020 | 10 | 16 |
| 2021 | 10 | 3 |
| 2022 | 4 | 10 |
| 2023 | 5 | 9 |
| 2024 | 3 | 9 |
| 2025 | 6 | 10 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for measuring COPD biomarkers25 Aug 2026US 12,716,898 B2St. John's University
- Methods and compositions for cardiovascular disease detection and management31 Mar 2026US 12,590,974 B2Ohio State Innovation Foundation
- Isoform-independent antibodies to lipoprotein(a)24 Feb 2026US 12,559,575 B2The Regents of the University of California
- Use of melanocortin-1 receptor agonist27 Jan 2026US 12,533,350 B2Tanabe Pharma Corporation
- Use of sCD14 or its fragments or derivatives for risk stratification, diagnosis and prognosis23 Sep 2025US 12,422,439 B2PHC Corporation
- Methods for detecting or treating atherosclerosis27 Aug 2026US 2026/0250372 A9City University of Hong Kong
- Methods and compositions for cardiovascular disease detection and management16 Jul 2026US 2026/0202425 A1Ohio State Innovation Foundation
- Methods to target the soluble urokinase plasminogen activator receptor pathway for the prevention and treatment of atherosclerosis11 Jun 2026US 2026/0158003 A1The Regents of the University of Michigan
- Inflammatory disease gene panel9 Apr 2026US 2026/0098305 A1Ludwig Enterprises, Inc
- Comp peptide and antibodies thereto for diagnosing osteoarthritis22 Jan 2026US 2026/0023084 A1SGPTH Life Science AB
Most cited
By later US patents
- Therapeutic inhibitor of vascular smooth muscle cells562US 5,733,925 ANeoRx Corporation · 1998
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Therapeutic inhibitor of vascular smooth muscle cells308US 6,074,659 ANoeRx Corporation · 2000
- Therapeutic inhibitor of vascular smooth muscle cells280US 5,811,447 ANeoRx Corporation · 1998
- Therapeutic inhibitor of vascular smooth muscle cells245US 6,171,609 B2NeoRx Corporation · 2001